Modelling the I-O manufacturing facilities of tomorrow

IMMUNO-ONCOLOGY INSIGHTS

Modelling the I-O manufacturing facilities of tomorrow

April 2021
Modelling the I-O manufacturing facilities of tomorrow
Download PDF

Foreword

Modelling the I-O manufacturing facilities of tomorrow

Modelling the I-O manufacturing facilities of tomorrow

23 April 2021
Read

Editorial

Outlook on manufacturing adoptive cell therapies for cancer immunotherapy

Outlook on manufacturing adoptive cell therapies for cancer immunotherapy

Xiuyan Wang, Isabelle Rivière
21 April 2021
Read

Commentary

Future-proofing cell therapy manufacturing capability: lessons from the NCI

Future-proofing cell therapy manufacturing capability: lessons from the NCI

Anthony Welch, Marc Ernstoff, Jason Yovandich
20 April 2021
Read

Interview

Key considerations in delivering tomorrow’s biopharma manufacturing facilities and workforce

Key considerations in delivering tomorrow’s biopharma manufacturing facilities and workforce

Edwin Huang
19 April 2021
Read
Driving a new model for point of care cellular cancer immunotherapy manufacturing

Driving a new model for point of care cellular cancer immunotherapy manufacturing

J Powderly, R Brent Dixon, J Montague et al.
16 April 2021
Read

Expert Roundtable Video

How to increase I-O manufacturing efficiency, flexibility, and productivity in line with expected future trends in supply and demand?

How to increase I-O manufacturing efficiency, flexibility, and productivity in line with expected future trends in supply and demand?

John Lunger, Vijay Yabannavar, Donna Rill
22 April 2021
Watch

Expert Roundtable

How to increase I-O manufacturing efficiency, flexibility, and productivity in line with expected future trends in supply and demand?

How to increase I-O manufacturing efficiency, flexibility, and productivity in line with expected future trends in supply and demand?

John Lunger
23 April 2021
Read